Cyclacel Pharmaceuticals
CYCC
CYCC
29 hedge funds and large institutions have $19.5M invested in Cyclacel Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
9
Closed
5
Calls
$206K
Puts
$157K
Net Calls
+$49K
Net Calls Change
+$44K
Top Buyers
1 |
TLP
1
Tri Locum Partners
New York
|
$2.76M |
2 |
SCM
2
Silverarc Capital Management
Boston,
Massachusetts
|
$2.05M |
3 |
3
Two Sigma Advisers
New York
|
$640K |
4 |
VF
4
Virtu Financial
New York
|
$106K |
5 |
AAA
5
Affinity Asset Advisors
New York
|
$2.11M |